Consultative Partner Over 30 years’ experience closely collaborating with companies to ensure high quality, reproducible products that drive scientific discovery. Custom CDMO Services From antibody scale-up and purification to advanced conjugation and assay development, our tailored services streamline your workflow and accelerate research. Wide-Ranging Applications Our products are optimized for diverse applications—including spatial biology, flow cytometry, in vivo studies, and in vitro assays—to empower researchers to uncover critical biological interactions. Advanced Production Techniques Our proprietary processes yield the purest monoclonal, recombinant, and polyclonal antibodies and proteins available, ensuring high-purity reagents that drive consistent, reproducible results. Quality & Standards Quality is non-negotiable -we strictly adhere to ISO 9001:2015 and ISO 13485:2016 standards, ensuring that every antibody and protein we produce meets rigorous performance and reliability benchmarks.
Looking for a particular Leinco Technologies employee's phone or email?
The Leinco Technologies annual revenue was $1 million in 2026.
W. Leinert Sr. is the President and CEO of Leinco Technologies.
32 people are employed at Leinco Technologies.
Leinco Technologies is based in Fenton, Missouri.
The NAICS codes for Leinco Technologies are [3254, 32, 325, 32541, 325414].
The SIC codes for Leinco Technologies are [28, 283].